Results 71 to 80 of about 5,244 (166)

Complete hematologic response in a patient with multiple pretreated angioimmunoblastic T‐cell lymphoma after belinostat therapy followed by allogeneic stem cell transplantation: A case report

Clinical Case Reports
Key Clinical Message Belinostat therapy followed by hematopoietic stem cell transplantation is a promising salvage strategy for heavily pretreated patients with peripheral T‐cell lymphoma.
Sigrid De Wilde, Carlos Graux
doaj   +1 more source

A Case of Angioimmunoblastic T-Cell Lymphoma

Journal of Clinical and Diagnostic Research
Angioimmunoblastic T-cell Lymphoma (AITL) is a rare type of peripheral T-cell lymphoma characterised by an aggressive clinical course and a poor response to current therapies. There is currently no standard of care for treatment.
Kanchan Dasharthrao Devde, Amol Gajanan Andhale, Amol Shankar Dongre, Himanshi Kaushik, Prerna Tekulware   +4 more
doaj   +1 more source

Delayed diagnosis of angioimmunoblast T-cell lymphoma presenting with immunoglobulin a vasculitis

Renal Failure
Although vasculitis and renal involvement might be associated with malignancy, they are rarely associated with lymphoproliferative diseases. We observed a case of immunoglobulin A vasculitis associated with segmental and focal glomerulonephritis in a ...
Lu Xu, Huihui Dong, Dandan Xue, Yiming Zhang, Xinjian Li   +4 more
doaj   +1 more source

EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS

Mediterranean Journal of Hematology and Infectious Diseases
Epstein-Barr virus (EBV) is a prevalent virus that can be detected in the vast majority of the population. Most people are asymptomatic and remain chronically infected throughout their lifetimes.
Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca   +2 more
doaj   +1 more source

Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL)

Frontiers in Oncology, 2019
Angioimmunoblastic T-cell lymphoma (AITL) is one of four major subtypes of nodal peripheral T cell lymphoma, characterized by its cell of origin, the follicular helper T-cell (TFH).
Kelsey Sokol, Saritha Kartan, William T. Johnson, Onder Alpdogan, Neda Nikbakht, Bradley M. Haverkos, Jerald Gong, Pierluigi Porcu   +7 more
doaj   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Real‐World Data on the p.Gly17Val RHOA Mutation in Diagnosing T Follicular Helper Cell Lymphomas

Cancer Medicine
Background T follicular helper (Tfh) cell lymphomas, including their most prevalent form, angioimmunoblastic T‐cell lymphoma, frequently present with clinical symptoms, such as fever and rash, accompanied by substantial immune cell infiltration within ...
Yuri Tsuboi, Keiichiro Hattori, Naoki Kurita, Yasuhito Suehara, Toru Nanmoku, Ryota Matsuoka, Ryota Ishii, Sakurako Suma, Kenichi Makishima, Yumiko Maruyama, Tatsuhiro Sakamoto, Takayasu Kato, Hidekazu Nishikii, Naoshi Obara, Daisuke Matsubara, Mamiko Sakata‐Yanagimoto   +15 more
doaj   +1 more source

TET2 germline mutation in a patient with sequential lymphoid malignancies: a novel case report

Annals of Hematology
We report a case of a 30-year-old male patient with a germline heterozygous TET2 R1354fs mutation, who successively developed three distinct lymphoid malignancies: mixed cellularity classical Hodgkin lymphoma (MCCHL), angioimmunoblastic T-cell lymphoma ...
Xia Mao, Kefeng Shen, Jin Wang, Zhiqiong Wang, Qilin Ao, Chunyan Wang, Min Xiao   +6 more
doaj   +1 more source